The Department of Justice Antitrust Division has advised several pharmaceutical companies that they can share competitive information regarding the status of their respective efforts to develop a COVID-19 treatment without...more
The District of Columbia District Court has again deferred its decision regarding whether to approve the merger between CVS Health and Aetna, a $69 billion transaction that was first announced back in December 2017. ...more
4/11/2019
/ Aetna ,
Antitrust Provisions ,
Competition ,
CVS ,
Department of Justice (DOJ) ,
Health Insurance ,
Joint Venture ,
Medicare Part D ,
Merger Controls ,
Pharmaceutical Industry ,
Pharmacies ,
Popular
Two pieces of related legislation that would prohibit so called “gag clauses” in contracts between pharmacists and health plans and pharmacy benefit managers (PBM’s) have been passed by both the Senate and the House....more
10/9/2018
/ Contract Terms ,
Disclosure ,
Drug Pricing ,
Health Insurance ,
Legislative Agendas ,
Medicare Advantage ,
Medicare Part D ,
Out-of-Pocket Expenses ,
Pending Legislation ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Trump Administration
On September 17, the United States Department of Justice (DOJ) Antitrust Division issued a “closing statement” in which it announced that it was closing its investigation into Cigna’s proposed acquisition of Express Scripts,...more
The leadership of the House Energy & Commerce Committee has called upon the Federal Trade Commission to undertake a retrospective review of past mergers involving pharmacy benefit managers (PBMs). ...more
Walgreens and Kroger have filed an antitrust action in the United States District Court for the Eastern District of Pennsylvania accusing Johnson & Johnson (J&J) of engaging in anticompetitive conduct designed to stymie the...more